Perioperative Complications of Radical Cystectomy After Induction Chemoradiotherapy in Bladder-sparing Protocol Against Muscle-invasive Bladder Cancer: A Single Institutional Retrospective Comparative Study with Primary Radical Cystectomy
Open Access
- 11 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 41 (12) , 1373-1379
Abstract
To compare rates of early morbidity after radical cystectomy in patients treated with or without induction chemoradiotherapy (CRT) using a standardized reporting methodology. All 193 consecutive patients undergoing radical cystectomy for bladder cancer between 1989 and 2010 were retrospectively reviewed. Induction chemoradiotherapy consists of radiation at 40 Gy to the small pelvis and two cycles of concurrent cisplatin at 20 mg/day for 5 days. Deaths within 90 days after radical cystectomy and complications arising within 30 days were recorded and graded according to the Clavien–Dindo classification. Grades 1–2 were considered minor; Grades 3–5 were considered major. Eighty-seven patients underwent radical cystectomy following chemoradiotherapy (chemoradiotherapy group) while the remaining 106 primarily underwent radical cystectomy (no chemoradiotherapy group). No Grade 4–5 complication was observed. Overall, 118 patients (61%) experienced 36 major and 122 minor complications. There was no significant difference in the incidence of overall complications between the chemoradiotherapy and no chemoradiotherapy groups (67 vs. 57%). Overall urinary anastomosis-related complications and major gastrointestinal complications, most of which were Grade 3 ileus, were more frequent in the chemoradiotherapy group than the no chemoradiotherapy group (11 vs. 2%, P = 0.007; and 14 vs. 4%, P = 0.02; respectively). Multivariate analysis identified induction chemoradiotherapy as an independent risk factor for overall urinary anastomosis-related complications (relative risk 6.0, P = 0.01) but not for major gastrointestinal complications. Induction chemoradiotherapy at 40 Gy in bladder-sparing protocols against MIBC is unlikely to increase the rate of severe complications of radical cystectomy.Keywords
This publication has 33 references indexed in Scilit:
- Differential Complication Rates Following Radical Cystectomy in the Irradiated and Nonirradiated PelvisEuropean Urology, 2010
- Bladder Preservation Therapy Conducted by Intra-arterial Chemotherapy and Radiotherapy for Muscle Invasive Bladder CancerJapanese Journal of Clinical Oncology, 2009
- Bladder‐sparing, combined‐modality approach for muscle‐invasive bladder cancerCancer, 2007
- Long-term outcome of radiation-based conservation therapy for invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2007
- Multimodality Bladder Preservation Therapy for Muscle-Invasive Bladder TumorsSeminars in Oncology, 2007
- Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI)Cancer, 2007
- Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2007
- Trimodality Treatment and Selective Organ Preservation for Bladder CancerJournal of Clinical Oncology, 2006
- Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancerBJU International, 2004
- A bladder preservation regimen using intra‐arterial chemotherapy and radiotherapy for invasive bladder cancer: A prospective studyInternational Journal of Urology, 2000